J Biol Chem, Vol. 274, Issue 32, 22217-22224, August 6, 1999
Single Amino Acid Substitutions Globally Suppress the Folding
Defects of Temperature-sensitive Folding Mutants of Phage P22 Coat
Protein*
Lili A.
Aramli and
Carolyn M.
Teschke
From the Department of Molecular and Cell Biology, University of
Connecticut, Storrs, Connecticut 06269-3125
 |
ABSTRACT |
The amino acid sequence of a polypeptide defines
both the folding pathway and the final three-dimensional structure of a
protein. Eighteen amino acid substitutions have been identified in
bacteriophage P22 coat protein that are defective in folding and cause
their folding intermediates to be substrates for GroEL and GroES. These temperature-sensitive folding (tsf) substitutions identify amino acids
that are critical for directing the folding of coat protein. Additional
amino acid residues that are critical to the folding process of P22
coat protein were identified by isolating second site suppressors of
the tsf coat proteins. Suppressor substitutions isolated from the phage
carrying the tsf coat protein substitutions included global
suppressors, which are substitutions capable of alleviating the folding
defects of numerous tsf coat protein mutants. In addition, potential
global and site-specific suppressors were isolated, as well as a group
of same site amino acid substitutions that had a less severe phenotype
than the tsf parent. The global suppressors were located at positions
163, 166, and 170 in the coat protein sequence and were 8-190 amino
acid residues away from the tsf parent. Although the folding of coat
proteins with tsf amino acid substitutions was improved by the global
suppressor substitutions, GroEL remained necessary for folding.
Therefore, we believe that the global suppressor sites identify a
region that is critical to the folding of coat protein.
 |
INTRODUCTION |
The primary amino acid sequence of a polypeptide encodes all the
information necessary to direct the folding pathway so that the final
three-dimensional structure of a protein is achieved (1). However, the
mechanism by which the code directs folding is not well understood.
Deciphering the code for protein folding has implications for human
health, as there are a number of diseases, such as the amyloid-based
diseases, cystic fibrosis, and prion-like diseases, that have been
related to the misfolding and aggregation of proteins (2, 3).
Additionally, recombinant DNA technologies utilized to produce valuable
proteins, such as insulin, often have problems with inclusion body
formation when those proteins are expressed in heterologous hosts
(4-6). Understanding how the amino acid sequence controls both folding
and misfolding will allow us to understand how these diseases and
other processes related to misfolding occur.
The complex process of folding has been predominantly investigated
in vitro by following the refolding of purified polypeptide chains from the chemically or physically denatured state. Another valuable approach to understanding the nature of protein grammar has
been through the use of genetic analysis. Site-directed and randomly
induced mutations have revealed residues that are important for
different functions, such as stability or activity of the protein
(7-9). Genetic methods have also identified residues that are specific
for folding. Residues of this type have been found in various proteins
including tailspike protein of bacteriophage P22 (10), bacterial
luciferase (11), D-lactate dehydrogenase (12), and
interleukin-1
(13).
To study the grammar encoded within the amino acid sequence, we utilize
bacteriophage P22 coat protein as our model system. Eighteen amino acid
substitutions at seventeen different sites in P22 coat protein have
been identified that render the production of viable phage
temperature-sensitive (14, 15). In vivo, the temperature-sensitive folding
(tsf)1 amino acid
substitutions dramatically reduce the yield of soluble coat protein
because the newly synthesized coat polypeptides aggregate to form
inclusion bodies prior to reaching the assembly-competent state (14,
16). Furthermore, the chaperonins GroEL and GroES (17) have been shown
to recognize and rescue a thermolabile folding intermediate (16, 18).
In vitro, the tsf amino acid substitutions do not
destabilize the folded monomeric subunit because differential scanning
calorimetry and denaturation by pressure or urea coat proteins with tsf
substitutions have shown them to be as stable as WT coat protein (19,
20). Recently, Teschke (21) demonstrated that proteins with tsf amino
acid substitutions display altered secondary and tertiary structure as
well as increased surface hydrophobicity, which may explain the
increased propensity of the folding intermediates with substitutions to
aggregate, as they do in vivo. Based on these observations, a basic model for the folding of coat proteins is suggested (Fig. 1). We envision the newly synthesized
polypeptide forming an intermediate that at permissive temperature
proceeds to an assembly-competent coat monomer, which, along with other
bacteriophage proteins, proceeds to the mature virion. However, at the
nonpermissive temperature, the tsf amino acid substitution creates an
aggregation-prone intermediate that forms inclusion bodies. The
suppressor substitution would prevent the tsf action.

View larger version (17K):
[in this window]
[in a new window]
|
Fig. 1.
Model of the folding pathway of P22 coat
protein carrying tsf amino acid substitutions. A
newly synthesized polypeptide forms an intermediate that at permissive
temperature proceeds to an assembly-competent coat monomer that is
necessary to form a capsid. At a nonpermissive temperature, the tsf
amino acid substitution results in an intermediate that is
aggregation-prone and forms inclusion bodies (14, 16). A suppressor
amino acid substitution prevents the tsf action.
|
|
As phage P22 is amenable to genetic manipulation, we have isolated
intragenic second site suppressors of the coat protein carrying tsf
amino acid substitutions. Traditionally, a search of second site
suppressors has been utilized to determine gene product interactions
(22-26). However, in this case, a survey of second site suppressors of
coat proteins with tsf amino acid substitutions could be expected to
reveal interactions between residues in the affected folding
intermediate, and not with proteins that interact with the tsf coat
protein because the folding of coat protein into monomeric units
normally proceeds without the interaction with other phage proteins
(27). If all the tsf substitutions affect the same intermediate in a
folding pathway, a set of suppressor amino acid substitutions that
stabilize the intermediate might be expected to be repeatedly isolated
from several tsf coat protein mutants. Such amino acid substitutions
would be known as global suppressors (28). Intragenic global
suppressors of folding mutants have been discovered in tsf mutants of
P22 tailspike protein (29), a temperature-sensitive mutant of the human
receptor-like protein-tyrosine phosphatase LAR (30), missense mutants
in
-lactamase (31), and destabilizing mutants of cytochrome
c (32). Alternatively, if the tsf amino acid substitutions
do not affect the folding in the same way, it would be unlikely that
the same suppressor sites would be isolated for several tsf coat
protein mutants; instead, site-specific suppressors of tsf coat protein
mutants would be isolated. Such suppressors have been found in tsf
mutant phage of P22 tailspike protein (29, 33). In the case of P22 tailspike protein, both global and site-specific suppressors have been
identified, suggesting that its folding intermediate can be stabilized
in a variety of ways.
Here, we have isolated intragenic second site suppressors of coat
proteins that have tsf amino acid substitutions. We found three global
suppressors in close proximity to one another that are capable of
alleviating the folding defects of seven tsf coat proteins that are
located 8-190 residues in the linear amino acid sequence away from its
respective suppressor substitution. The majority of suppressor amino
acid substitutions are still dependent on GroEL/S action. In addition,
we have identified numerous same site and site-specific suppressors, as
well as potential global suppressors. The global suppressors identify
a region critical to proper folding of coat protein.
 |
EXPERIMENTAL PROCEDURES |
Bacteria--
The bacteria used for most of the experiments were
derivatives of Salmonella typhimurium LT2. The amber
suppressor minus host DB7136 (leuA414-am, hisC525-am) and
its amber suppressor plus derivative DB7155 (leu A414-am, his
C525-am, supE20-gln) have been described previously (34). The
strains DB7000 (leuA414-am) and DB7155 were transformed with
pOF39, which carries the groEL/S operon behind its own promoter (35).
This plasmid conferred ampicillin resistance to the cells. The
Escherichia coli strains (36, 37) DW720 (WT groEL
and groES) and DW716 (groEL44) were transformed
with the plasmid pPR1347 (38), which encodes for the rfb
gene cluster and rfc gene so that the E. coli
synthesized the O antigen needed for P22. The plasmid conferred
kanamycin resistance to the cells.
Bacteriophage--
All phage strains used in these experiments
carried the c1-7 allele, which prevents lysogeny. The P22 bacteriophage
used in this study were either WT in gene 5 or carried the
tsf mutations in gene 5 that lead to 18 amino acid
substitutions (14) (Fig. 2).

View larger version (7K):
[in this window]
[in a new window]
|
Fig. 2.
Map of tsf amino acid
substitutions of phage P22 coat protein. Each of the phage
carrying a tsf coat protein was used in the independent isolation of
intragenic suppressors. The complete sequence of gene 5 has
been determined by Eppler et al. (43). The tsf sites were
identified by Gordon and King (14). The amino acid preceding the
position number is the WT amino acid. The amino acid after the position
number is the tsf amino acid substitution.
|
|
Media--
Luria broth was prepared as described by Life
Technologies, Inc. and was used to support bacterial growth for plating
experiments, preparation of phage stocks, and single step growth curve
experiments. M9 medium was 0.6% Na2HPO4, 0.3%
KH2PO4, 0.05% NaCl, 0.01% NH4Cl. M9/Mg2+ medium was used for phage stock preparation and
contained M9 with 2 mM MgCl2. Dilution fluid
was used to dilute the phage stocks and contained 0.1% Tryptone, 0.7%
NaCl, and 2 mM MgSO4 (15)
Preparation of Phage Stocks--
A single fresh plaque was added
to 30 ml of LB with logarithmically growing DB7136 cells and aerated by
shaking at 30 °C until lysis occurred or a maximum of 6 h. Two
to three drops of chloroform were added to ensure complete lysis of
infected cells. Samples were chilled on ice for 15 min, and the cell
debris was pelleted at 10,000 rpm for 10 min in a SL-50T Sorvall rotor.
Phage in supernatant were pelleted by a 90-min centrifugation at 18,000 rpm in the SL-50T rotor. The pellets were drained and resuspended
overnight in 2 ml of M9/Mg2+. A second 10-min
centrifugation at 10,000 rpm removed residual debris (15).
Isolation of Revertants of tsf Mutant Coat Proteins--
To
obtain independent revertants, plaques were isolated at the
nonpermissive temperature for each phage carrying coat protein with a
tsf amino acid substitution by plating approximately 106
phage on each plate. Each plaque is an independent isolation of the tsf
phage (33, 39). Ten to 20 revertant plaques from each plate for each
tsf allele were picked and purified three times by plating a single
plaque sequentially. Phage stocks were prepared from one purified
plaque at 30 °C.
PCR Amplification of Specific Alleles (PASA)--
To screen the
tsf revertants, PASA analysis (40-42) was utilized to discriminate
between WT revertants and pseudorevertants. Pseudorevertants are
mutants that retain the tsf amino acid substitution but have an
additional substitution elsewhere. Phage stocks of concentrations
1010 to 1011 phage/ml were filter sterilized
(Nalgene syringe filter, 0.2 µm syringe filter). Each 100-µl
polymerase chain reaction (PCR) vessel contained 1 µl of sterile
filtered phage stock (107 to 108 phage), 2.5 units of Amplitaq DNA polymerase (Perkin-Elmer), 200 µM
each nucleotide (Perkin-Elmer, Gene Amp dNTPs), 1× PCR Buffer II, 1 mM MgCl2, 50 pmol each of reverse primer and
specific PASA primer (Table I). PCR
vessels were exposed for 4 min at 94 °C, 25 cycles of 30 s at
94 °C, followed by 30 s at annealing temperature (varying
70-80 °C), extension for 1 min at 72 °C, and finally 7 min at
72 °C, and then chilled to 4 °C in a Perkin-Elmer Gene Amp PCR
system 2400. The optimal conditions for the various PASA-specific
primers were determined by changing the annealing temperature. A
reverse primer was synthesized to be complimentary to bases 6480-6459
(43), and another primer was synthesized to be complementary to either
the WT nucleotide sequence or to the tsf nucleotide sequence (Table I).
The nucleotide numbering is based on the P22 DNA sequence in
GenBankTM (accession number M59749). For primer
descriptions, the first number represents the 5'-end of the primer and
the last number represents the 3'-end of the primer. An agarose gel
(1%) was used to determine whether amplified product was present.
PCR Amplification and Purification--
PCR was utilized to
amplify gene 5, which encodes coat protein, from
bacteriophage stocks. One µl of filtered phage stock (107-108 phage) was amplified with final
concentration of 2.5 units of high efficiency polymerase (Pwo DNA
polymerase from Roche Molecular Biochemicals); 200 µM
each ATP, CTP, GTP, and TTP (deoxynucleoside triphosphate set, PCR
grade, Roche Molecular Biochemicals); 1× PCR buffer with 0.2 mM MgSO4; and 50 pmol of each forward (14) and
reverse primer (Table I). The PCR vessels were exposed to the same
procedure as described above except that the annealing temperature was
55 °C. The amplified PCR product was purified using a high pure PCR
purification kit (Roche Molecular Biochemicals). An agarose gel (1%)
was used to determine quantity and purity of PCR-amplified product.
DNA Sequence Analysis--
The P22 packaging genes have been
sequenced, including gene 5, which encodes coat protein
(43). To determine the sequence of the tsf pseudorevertants, Sequenase,
Version 2.0, DNA sequencing kit (Amersham Pharmacia Biotech) was used
following the manufacturer's instructions with the following
modifications. Nine µl of purified PCR product were denatured in the
presence of 1 µl of sequencing primer (5-50 pmol/µl) (Table I) for
5 min at 100 °C. The samples were then cooled on ice for 5 min.
Dithiothritol, diluted labeling mix (1:5), T7 Sequenase reaction
buffer, [
-35S]dATP (NEN Life Science Products), and
diluted T7 Sequenase were added to the ice-cold annealed DNA mixture.
The reactants were mixed and incubated for 5 min at room temperature.
Sequencing reactions were terminated by incubation at 45 °C for 5 min with the dideoxy nucleotides. The sequencing primer was selected
based on the region of gene 5 to be sequenced (Table I). The
reactions were heated to 80 °C prior to loading (4 µl) on a 6%
acrylamide/bisacrylamide gel containing 7 M urea and 1×
glycerol-tolerant gel buffer. GTG buffer was prepared at 20× and
contained 1.78 M Tris, 0.57 M taurine, and 0.01 M EDTA Na2·2H20, pH 8.9. The
sequencing gel was dried and exposed to film (Biomax-MR Kodak) and
developed the following day.
Efficiency of Plating--
Phage were either WT in coat protein,
carried coat protein with tsf amino acid substitutions, or coat protein
with tsf and suppressor amino acid substitutions (tsf/su). The phage
were plated at various temperatures from 16 to 41 °C on S. typhimurium DB7136 or DB7155 with and without the plasmid pOF39 or
on E. coli DW720 and DW716 strains with the plasmid pPR1347
(38). Plating efficiencies were calculated by dividing the titer of the
phage grown at each temperature by the titer produced when phage were
grown at 22 °C on each bacterial strain (14).
Single-step Growth Curves--
Salmonella DB7136 host
cells were infected at the nonpermissive temperature with WT phage,
phage carrying coat protein with tsf amino acid substitutions, or the
double tsf/su amino acid substitutions in coat protein, at a
multiplicity of infection of 10. At times after infection, samples were
lysed with chloroform and plated at permissive temperature (15). The
number of phage produced per cell was calculated.
 |
RESULTS |
Previously, a group of amino acid substitutions at multiple sites
in P22 coat protein have been characterized that cause a tsf phenotype
(14). These amino acid substitutions identify residues important for
proper folding of coat protein. Suppressors of 18 tsf coat protein
mutants have been isolated in order to determine the positions of
additional amino acids crucial to stabilizing the folding
intermediate(s) affected by the tsf amino acid substitutions. Here, we
report the isolation of global suppressors of folding mutants in phage
P22 coat protein.
Isolation of tsf Revertants--
Over 260 independent revertants
of 18 different phage carrying coat protein with a tsf amino acid
substitution (Fig. 2) were isolated on S. typhimurium with
and without increased GroEL/S levels at the nonpermissive temperature
of the tsf parent phage. The reversion frequencies, which ranged from
10
5 to 10
7, were consistent with single
nucleotide substitutions (data not shown). To determine whether the
revertants were wild-type revertants or pseudorevertants, an
analysis known as PASA, described in detail under "Experimental
Procedures," was used to discriminate between the two (40-42). To
confirm the results of PASA analysis, gene 5 of P22 was
amplified, and the region corresponding to the original tsf nucleotide
substitution was sequenced. Those suppressor mutants that retained the
original tsf nucleotide substitution were further sequenced to identify
the site of the suppressor nucleotide substitution.
Identification of Second Site Suppressors--
The location and
identity of second site suppressors was determined by DNA sequence
analysis. Intragenic suppressors were isolated from phage carrying the
tsf coat protein substitutions A108V, D174N, D174G, S223F, S262F,
G282D, T294I, D302G, P310A, G403D, F353L, Y411H, and P418S. While
second site suppressors were isolated from the majority of these tsf
coat proteins, four of the tsf mutant coat proteins only reverted to
the WT amino acid. These mutants were W48Q, P238S, V297A, and V300A.
The suppressors of the 14 remaining tsf mutant coat proteins were
grouped into five categories: same site substitutions, site-specific
suppressors, global suppressors, potential global suppressors, and
extragenic suppressors. Intracodon nucleotide substitutions resulting
in the change of the tsf substitution to another amino acid were found
for D174N, D174G, S262F, D302G, and G403D and have been categorized as
same site substitutions (Table II). In
addition to these same site suppressors, there were a few suppressors
that were found with only one tsf coat protein parent and at a low frequency, which we have categorized as site-specific suppressors (Table III). We also isolated one
potential extragenic suppressor of G232D.
The majority of second site suppressors that were not categorized as
site-specific or same site substitutions were found in the
amino-terminal region of coat protein. The suppressor amino acid
substitutions D163G, T166I, and F170L were independently isolated from
seven tsf coat protein mutants, A108V, D174N, D174G, S223F, G282D,
T294I, and F353L, and ranged from 8 to 190 in the linear amino acid
sequence from the original tsf amino acid substitution (Table
IV). These types of suppressors are
described as a global suppressors as they were able to suppress the
phenotype of multiple tsf parents. In addition, a group of potential
global suppressors has been isolated. These suppressors have been
categorized as such because the number of tsf parents from which the
suppressors had been isolated was fewer than that of the global
suppressors. A more extensive search may have found these suppressors
to be global suppressors (Table V). In
addition, two of the site-specific suppressors, D135H and A136D, could
be global suppressors because the folding defect of the tsf parents of
these particular suppressor substitutions was also alleviated by the
global suppressors, and they were found next to one another in sequence
(Table III). Gordon and King (15) also performed a limited search for
intragenic second site suppressors to confirm that the tsf amino acid
substitutions affected the folding process. In that search, a number of
true revertants were isolated, as well as S223F/F170L and P310A/A263S (15). In addition, the silent mutations that Gordon and King (14) had
identified in various tsf phage strains were also found in our
study.
Effect of Suppressor Substitutions on Phage Biogenesis--
To
determine the limits of the effectiveness of the suppressor amino acid
substitutions to mitigate the folding defects, efficiency of plating
experiments were performed with tsf and tsf/su phages (Fig.
3). The presence of a suppressor amino
acid substitution alleviated the defect due to the tsf amino acid
substitution at the temperature used for selection; however, some were
more effective at restoring growth at higher temperatures than others.
For instance, of the site-specific and potential global suppressors of
the tsf coat protein parent P310A, P310A/A337G increased the minimum
restrictive temperature from 33 to 41 °C, which is higher than
P310A/D85V, P310A/A263S, or P310A/D303G, which could not suppress the
folding defect at temperatures greater than 37 °C (Fig. 3). In
comparison, the global suppressors of S223F and F353L completely
restored the phenotype to that of WT phages, which can grow at
temperatures up to 41 °C. The relative plating efficiencies were
also determined for other tsf coat protein parents and their
suppressors. Overall, the global suppressors restored the phenotype of
the tsf coat protein mutants to that of WT phage (data not shown).
Additionally, we discovered that the tsf coat protein parent, G282D,
and the suppressor substitution, N414T, isolated from Y411H and P418S resulted in a cold-sensitive phenotype (data not shown). A substitution of serine at position 414 has previously been identified as a cold-sensitive mutant (14, 21, 44).

View larger version (32K):
[in this window]
[in a new window]
|
Fig. 3.
Efficiency of plating of P22 with tsf
and tsf/su mutant coat proteins on
different cell strains. Phage that were WT in coat protein or
carried tsf or tsf/su coat proteins were plated at various temperatures
on normal cells (DB7136), cells that overproduce GroEL/S
(DB7000/pOF39), and cells that carry mutant GroEL
(DW716/groEL44). The efficiency of plating is the ratio of
the titer of phage in the experimental condition to the titer of phage
observed at the most permissive temperature.
|
|
Effect of GroEL and GroES on Phage Biogenesis--
To
understand the effect of the chaperonins GroEL and GroES on the
biogenesis phage with tsf and tsf/su coat proteins, a series of plating
experiments were performed. The phage were plated on cells that
overexpress the chaperonin complex, GroEL/S by approximately 9-fold
(18). The minimum restrictive temperature of the phages with tsf and
tsf/su coat protein was increased by approximately 2 °C, unless the
suppressor already completely restored the tsf phenotype to that of WT
phage (Fig. 3). This result was consistent with previous experiments
(16, 18) and suggested that the folding intermediates of coat protein
with tsf amino acid substitutions are recognized by GroEL/S.
To determine whether functional GroEL is required for the folding of
tsf and tsf/su coat protein mutants, phage carrying these substitutions
were plated on a strain of cells that carry a point mutation in GroEL
that causes a substitution from glutamic acid to glycine at position
191 (GroEL44) (37). Cells that contain this substitution in GroEL are
dysfunctional, because a number of different bacteriophage can not grow
on this strain (37). Our plating experiments revealed that the minimum
restrictive growth temperature decreased for both the tsf and tsf/su
coat protein mutants when plated on the GroEL44 strain, although the suppressors still maintained a higher minimum restrictive temperature than the tsf parent. This result indicates that functional GroEL was
important for proper folding of tsf coat proteins, even with the
suppressor amino acid substitution present. Interestingly, P310A/D85V
maintained the same minimum growth restrictive temperature on the
GroEL44 strain as when plated on the normal cell line. From this
experiment, we might conclude that P310A/D85V does not require
functional GroEL to fold productively. However, increased levels of
GroEL/S increased the minimum restrictive temperature of P310A/D85V.
Therefore, for this suppressor functional GroEL improves folding
efficiency, perhaps because the suppressor amino acid substitution did
not completely correct the folding defect, but GroEL may not be as
essential for productive folding at P310A/D85V minimum restrictive
temperature. Nevertheless, tsf/su coat protein mutants that we examined
still required GroEL for proper folding.
Effect of Second Site Suppressor Mutations in Liquid
Culture--
To examine the effect of the suppressor amino acid
substitutions on the kinetics and yield of phage production, single
step growth curves at the restrictive growth temperature of the tsf parent were performed. The single step growth curve shows the genesis
of viable phage as a function of time after infection. The phage with
the coat protein mutants S223F and P310A were selected for two reasons.
First, the suppressors of each mutant represent the main types of
suppressors: global, potential global, and site-specific suppressors.
Second, the tsf coat protein mutants S223F and P310A are
temperature-sensitive at 37 and 33 °C, respectively; therefore, the
rate-limiting step in phage morphogenesis would not be the production
of tailspike protein, as it is at high temperatures (29). These curves,
then, indirectly reflect the ability of each coat protein to
productively fold and assemble into a mature virion.
The phage with the tsf coat protein mutant P310A is restricted for
growth at 33 °C, whereas the second site suppressors of the parent
mutant increase the minimum restrictive temperature, as seen by
efficiency of plating experiments (Fig. 3). The growth curve of P310A
and its tsf suppressors at 33 °C showed differences in both the rate
of production and yield of phage (Fig.
4). The coat protein mutant P310A had a
burst of ~20 phage/cell, in contrast to the wild-type phage strain,
which had a burst of ~600 phage/cell at 33 °C. The tsf/su phage,
P310A/D85V, yielded a burst of ~60 phage/cell, P310A/A263S a burst of
~160 phage/cell, P310A/D303G a burst of ~70 phage/cell, and
P310A/A337G a burst of ~800 phage/cell; the range was therefore from
10% to approximately 130% of the WT burst.

View larger version (22K):
[in this window]
[in a new window]
|
Fig. 4.
Single step growth curve. Exponentially
growing DB7136 cells were infected with WT phage, phage with tsf coat
proteins (S223F or P310A), or phage with tsf/su coat proteins. At the
designated times after infection, samples were lysed with chloroform
and plated at the permissive temperature. Left panel: WT,
; S223F, ; S223F/D135H, ; S223F/D163G, ; S223F/T166I,
+; S223F/F170L, ×. Right panel: WT,
; P310A, ; P310A/D85V, ; P310A/A263S, ; P310A/D303G,
+; P310A/A337G, ×.
|
|
The suppressors of S223F alleviated its folding defects as demonstrated
by efficiency of plating experiments (Fig. 3). The levels of phage
produced by phage with the tsf coat protein mutant S223F were less than
1 phage/cell at 37 °C, compared with WT phage, which produced ~530
phage/cell (Fig. 4). The suppressors improved the yield of phage
produced significantly when compared with the tsf parent. With the
global suppressors S223F/D163G, S223F/T166I, and S223F/F170L and
potential global suppressor S223F/D135H, the amount of phage produced
per cell was greater than levels produced by the site-specific and
potential global suppressors of P310A. The exception was P310A/A337G,
which improved the yield and rate of kinetics of phage production to
levels greater than that of WT phage. Thus, the suppressors were better
able to alleviate the folding defect of S223F than P310A, which might
be expected because the folding defect caused by P310A is more severe
than that caused by S223F. Of the global suppressors of S223F,
S223F/T166I restored the phage growth curve to that of WT phenotype.
 |
DISCUSSION |
Amino acid residues, as defined by both their position and
chemistry, have functionally different roles in the structure of a
protein, including its activity, stability and folding. While the
function of one amino acid does not exclude the possibility of another
function for that amino acid, only a portion of the amino acids of a
polypeptide are necessary for directing the conformation of the chain
through its folding intermediates to its final folded state (10-13).
Isolating mutants that interfere with polypeptide folding is one method
of identifying the residues that are critical for defining the
conformation of the folding intermediates (45). Another way to identify
residues important to the folding process is to isolate suppressors of
folding mutants (28-32, 39). These suppressors may also be useful in
analyzing the steps that lead to nonproductive folding pathways, such
as inclusion body formation, because these now correct the folding
defect of the original mutants hosts (5, 6, 46-51).
Analysis of the Location of the tsf Mutations--
The nucleotide
substitutions resulting in a temperature-sensitive phenotype in gene
5 of P22 were isolated by chemical and UV mutagenesis, as
revertants of mutant bacteriophage gene product 1, or as revertants of
a gene 5 amber mutant (14, 22, 52, 53). Using a variety of
methods, the amino acid substitutions in coat protein of P22 were
discovered to be important to the folding process (14-16, 18-21,
54-56). Although the tsf amino acid substitutions are found throughout
the entire sequence of coat protein, the majority of the tsf
substitutions are located in the carboxyl-terminal portion of the
protein. The bias in the location of the tsf amino acid substitutions
could be due to incomplete saturation of the coat protein gene during
the mutagenesis that produced these phages. Alternatively, the amino
terminus of coat protein may not give rise to tsf amino acid
substitutions either because the substitutions lead to a lethal
phenotype or because they are silent mutations, neither of which would
be identified in a screen for conditional-lethal mutants. These
possibilities are currently being
investigated.2
At present, the locations of the tsf amino acid substitutions in the
three-dimensional structure of coat protein are unknown, as the
structure has not been solved. Using the Kyte-Doolittle hydropathy
calculation, Gordon and King (15) were unable to discover any pattern
in the tsf coat protein amino acid substitutions. However, based on
current experiments in our lab, we are able to conclude that the phages
carrying coat protein with a tsf amino acid substitution, D174G/N,
S223F and G232D are located on the surface of
procapsids.3
To help us analyze the effects of the tsf and tsf/su amino acid
substitutions, the Discrimination of Secondary structure Class prediction model of King and Sternberg (51) was utilized to generate a
secondary structure prediction of P22 coat protein (Fig.
5). This program was chosen because the
fractions of predicted secondary structure of P22 coat protein closely
resemble data attained by circular dichroism and Raman spectroscopies
(54, 57, 58). In addition, the proteins that were used to generate the
data base of protein structures contain percentages of secondary structure similar to that of P22 coat protein. Using this model, the
tsf amino acid substitutions are predicted to be in helix, sheet, and
irregular structures. However, 89% of the tsf amino acid substitutions
are predicted to be in either
-sheets or irregularly structured
regions. The high frequency of tsf amino acid substitutions isolated in
these regions may be due to the nature of these structural elements.
The
-sheets require interactions that are distant in the primary
sequence to stabilize the
-strands, and irregularly structured
regions are necessary for turns in the structure, which allow
interactions of other structural elements (59, 60).

View larger version (25K):
[in this window]
[in a new window]
|
Fig. 5.
Secondary structure prediction of P22 coat
protein. Discrimination of protein Secondary structure Class
analysis is based on the study of King and Sternberg (51). The protein
data set comprises 126 globular proteins that have 32% -helix
conformation, 22% -strand conformation, and 47% coil formation,
including turns. Discrimination of protein Secondary structure Class
analysis evaluates every amino acid residue in a window of 17 to
predict secondary structure. The irregularly structured regions are
represented by thick solid lines, helices are
represented by a barrel-like structure, and the -strand
is represented by an arrow. Placed above the predicted
secondary structure are stars, which represent the sites of
the suppressor substitutions, and open circles, which
identify the sites of tsf amino acid substitutions. Solid
lines are drawn between a tsf parent and the global suppressor
isolated from it.
|
|
The Sites of the Global Suppressors--
Based on DNA sequence
analysis, we identified the nucleotide substitutions of the tsf
pseudorevertants. Three amino acid substitutions at positions 163, 166, and 170 of coat protein were able to suppress folding defects
resulting from a number of different tsf amino acid substitutions. The
repeated isolation of the three global suppressors, located in close
proximity to one another, strongly supports the notion that these amino
acid substitutions have an important role in coat protein folding.
We believe that the global suppressors are located at or near the
surface of the coat protein. This hypothesis is based on a number of
observations. First, as discussed above, the amino acid at position 174 has previously been determined to be located at the surface of the coat
protein.3 Second, the suppressor amino acid substitutions
at positions 163 and 166 themselves are nonconservative in nature.
Nonconservative substitutions are often localized in regions of
proteins that can tolerate such substitutions, such as loops and other
flexible conformational motifs (61). Whereas the suppressor
substitution of leucine from phenylalanine at position 170 is a
relatively conservative substitution, substitutions of aromatic
residues with leucine have been shown to have a significant impact on
the distribution of folding intermediates and the stability of the folding intermediates and native-like structure (62, 63). In
addition, Van der Schueren et al. (64) recently
demonstrated that a single site substitution of leucine to
phenylalanine prevented aggregation of the truncated choramphenicol
acetyltransferase, thereby improving the folding. Intriguingly, the
Discrimination of Secondary structure Class analysis of P22 coat
protein placed the global suppressor substitutions in a predicted
irregularly structured region (Fig. 5). Based on a model suggested by
Tuma et al. (65) in which the coat protein is proposed to
consist of two domains joined by a hinge region, and on our biochemical data, one feasible hypothesis is that the suppressor amino acid substitutions are located in or very near to this hinge region. The
hinge region has been suggested to be critical to the domain movement
of coat protein that occurs during expansion of the capsid lattice.
Proper formation of this hinge region may also be important during folding.
Models of Suppression--
The global suppressor amino acid
substitutions localize to a predicted irregularly structured region
(Fig. 5). Because the tsf amino acid substitutions are far apart in
sequence, we believe they are unlikely to each interact with the global
suppressors in a site-specific fashion. Consequently, it is more
probable that the global suppressor amino acid substitutions stabilize an aggregation-prone folding intermediate, change the kinetics of
folding or unfolding in a way that compensates for the effect of the
tsf amino acid substitutions, retard the rate of the off-pathway aggregation reaction, or destabilize incorrect conformations (48). Conversely, the site-specific suppressor amino acid substitutions may
suppress the folding defect through direct side chain interactions.
One conundrum of the global suppressor amino acid substitutions is why
these amino acids are not found in the WT coat protein sequence because
they appear to improve folding. They may not have evolved for reasons
other than folding, such as a change in the stability of coat protein
or a decrease in the efficiency of other interactions necessary to
permit proper assembly and maturation of the virion. It is also
possible that individually the suppressor substitutions may have a
deleterious effect on folding. A similar mutational analysis was
performed with P22 tailspike protein (29, 39, 66). The search for
suppressors of tailspike tsf mutants realized two global suppressors,
V331A and A334V (29, 33). The global suppressor amino acid
substitutions have been shown to improve folding efficiency in
vitro and in vivo. Based on biochemical studies and the
solved structure of truncated P22 tailspike protein (67, 68), it has
been determined that the two suppressor substitutions operate through
different modes of action (69). The suppressor, V331A, alleviates the tsf folding defects by stabilizing the completely folded protein, and
based on its location in the tailspike structure, the substitution functions by removing a steric hindrance. The suppressor, A334V, alleviates the folding defects by accelerating unfolding at high temperature, which decreases stability of the tailspike protein by
improving hydrophobic stacking in an early folding intermediate but
destabilizes the native protein. These global suppressor substitutions have not evolved naturally, as they are located in the active site
region of tailspike protein, where their respective amino acid
substitutions improve folding but interfere with function.
Here we have isolated three global suppressors, D163G, T166I, and
F170L, which are capable of alleviating the folding defects of multiple
tsf coat protein parents. While the suppressors improve the folding of
the tsf parents, the tsf/su mutant coat proteins are still dependent on
GroEL/S. Future investigations will probe the mechanism by which the
global suppressor substitutions alleviate the folding defects of the
tsf parents.
 |
ACKNOWLEDGEMENTS |
We thank Dr. Charles Giardina for use of the
Perkin-Elmer PCR system, Dr. David Knecht for suggesting the use of
PASA to screen our mutants, and Dr. Sherwood Casjens for GroEL/S
overproducing and mutant bacterial strains.
 |
FOOTNOTES |
*
This work was supported by National Institutes of Health
Grant GM53567 and the Patrick and Catherine Weldon Donaghue Foundation Grant 95-001.The costs of publication of this
article were defrayed in part by the
payment of page charges. The article
must therefore be hereby marked
"advertisement" in
accordance with 18 U.S.C. Section
1734 solely to indicate this fact.
To whom correspondence should be addressed: Dept. of Molecular and
Cell Biology, University of Connecticut, 75 N. Eagleville Rd., U-3125,
Storrs, CT 06269-3125. Tel.: 860-486-4282; Fax: 860-486-4331; E-mail:
teschke@uconnvm.uconn.edu.
2
H. B. Whitlatch and C. M. Teschke, unpublished results.
3
C. M. Capen and C. M. Teschke, unpublished results.
 |
ABBREVIATIONS |
The abbreviations used are:
tsf, temperature-sensitive folding;
WT, wild-type;
PCR, polymerase chain
reaction;
PASA, PCR amplification of specific alleles;
tsf/su, tsf coat
protein mutant with a suppressor amino acid substitution.
 |
REFERENCES |
| 1.
|
Anfinsen, C. B.
(1973)
Science
181,
223-230[Free Full Text]
|
| 2.
|
Thomas, P. J.,
Qu, B.-H.,
and Pedersen, P. L.
(1995)
Trends Biochem. Sci.
20,
456-459[CrossRef][Medline]
[Order article via Infotrieve]
|
| 3.
|
Welch, W. J.,
and Brown, C. R.
(1996)
Cell Stress Chaperones
1,
109-115
[CrossRef][Medline]
[Order article via Infotrieve] |
| 4.
|
Marston, F. A. O.
(1986)
Biochem. J.
240,
1-12[Medline]
[Order article via Infotrieve]
|
| 5.
|
Mitraki, A.,
and King, J.
(1989)
Bio/Technology
7,
690-697[CrossRef]
|
| 6.
|
Betts, S.,
Haase-Pettingell, C.,
and King, J.
(1997)
Adv. Protein Chem.
50,
243-264[Medline]
[Order article via Infotrieve]
|
| 7.
|
Beasty, A. M.,
Hurle, M.,
Manz, J. T.,
Stackhouse, T.,
and Matthews, C. R.
(1987)
Protein Eng.
1,
91-102
|
| 8.
|
Goldenberg, D. P.
(1988)
Annu. Rev. Biophys. Chem.
17,
481-507[CrossRef][Medline]
[Order article via Infotrieve]
|
| 9.
|
Shortle, D.
(1989)
J. Biol. Chem.
264,
5315-5318[Free Full Text]
|
| 10.
|
Goldenberg, D.,
and King, J.
(1981)
J. Mol. Biol.
145,
633-651[CrossRef][Medline]
[Order article via Infotrieve]
|
| 11.
|
Sugihara, J.,
and Baldwin, T. O.
(1988)
Biochemistry
27,
2872-2880[CrossRef][Medline]
[Order article via Infotrieve]
|
| 12.
|
Truong, H.-T. N.,
Pratt, E. A.,
Rule, G. S.,
Hsue, P. Y.,
and Ho, C.
(1991)
Biochemistry
30,
10722-10729[CrossRef][Medline]
[Order article via Infotrieve]
|
| 13.
|
Chrunyk, B. A.,
Evans, J.,
Lillquist, J.,
Young, P.,
and Wetzel, R.
(1993)
J. Biol. Chem.
268,
18053-18061[Abstract/Free Full Text]
|
| 14.
|
Gordon, C. L.,
and King, J.
(1993)
J. Biol. Chem.
268,
9358-9368[Abstract/Free Full Text]
|
| 15.
|
Gordon, C. L.,
and King, J.
(1994)
Genetics
136,
427-438[Abstract]
|
| 16.
|
Nakonechny, W. S.,
and Teschke, C. M.
(1998)
J. Biol. Chem.
273,
27236-27244[Abstract/Free Full Text]
|
| 17.
|
Fenton, W. A.,
and Horwich, A. L.
(1997)
Protein Sci.
6,
743-760[Abstract]
|
| 18.
|
Gordon, C. L.,
Sather, S. K.,
Casjens, S.,
and King, J.
(1994)
J. Biol. Chem.
269,
27941-27951[Abstract/Free Full Text]
|
| 19.
|
Foguel, D.,
Teschke, C. M.,
Prevelige, P. E., Jr.,
and Silva, J. L.
(1995)
Biochemistry
34,
1120-1126[CrossRef][Medline]
[Order article via Infotrieve]
|
| 20.
|
Galisteo, M. L.,
Gordon, C. L.,
and King, J.
(1995)
J. Biol. Chem.
270,
16595-16601[Abstract/Free Full Text]
|
| 21.
|
Teschke, C. M.
(1999)
Biochemistry
38,
2873-2881[CrossRef][Medline]
[Order article via Infotrieve]
|
| 22.
|
Jarvik, J.,
and Botstein, D.
(1975)
Proc. Natl. Acad. Sci. U. S. A.
72,
2738-2742[Abstract/Free Full Text]
|
| 23.
|
Moir, D.,
and Botstein, D. B.
(1982)
Genetics
100,
565-577[Abstract/Free Full Text]
|
| 24.
|
Han, M.,
Aroian, R. V.,
and Sternberg, P. W.
(1990)
Genetics
126,
899-913[Abstract]
|
| 25.
|
Lux, F. G., III,
and Dutcher, S. K.
(1991)
Genetics
128,
549-561[Abstract]
|
| 26.
|
Nelson, R. J.,
Ziegelhoffer, T.,
Nicolet, C.,
Werner-Washburne, M.,
and Craig, E. A.
(1992)
Cell
71,
97-105[CrossRef][Medline]
[Order article via Infotrieve]
|
| 27.
|
Prevelige, P. E., Jr.,
Thomas, D.,
and King, J.
(1993)
Biophys. J.
64,
824-835[Abstract/Free Full Text]
|
| 28.
|
Shortle, D.,
and Lin, B.
(1985)
Genetics
110,
539-555[Abstract/Free Full Text]
|
| 29.
|
Fane, B.,
Villafane, R.,
Mitraki, A.,
and King, J.
(1991)
J. Biol. Chem.
266,
11640-11648[Abstract/Free Full Text]
|
| 30.
|
Tsai, A. Y. M.,
Toh, M.,
Streuli, M.,
Thai, T.,
and Saito, H.
(1991)
J. Biol. Chem.
266,
10534-10543[Abstract/Free Full Text]
|
| 31.
|
Huang, W.,
and Palskill, T.
(1997)
Proc. Natl. Acad. Sci. U. S. A.
94,
8801-8806[Abstract/Free Full Text]
|
| 32.
|
McGee, W. A.,
and Nall, B. T.
(1998)
Protein Sci.
7,
1071-1082[Abstract]
|
| 33.
|
Villafane, R.,
Fleming, A.,
and Haase-Pettingell, C.
(1994)
J. Bacteriol.
176,
137-142[Abstract/Free Full Text]
|
| 34.
|
Winston, R.,
Botstein, D.,
and Miller, J. H.
(1979)
J. Bacteriol.
137,
433-439[Abstract/Free Full Text]
|
| 35.
|
Fayet, O.,
Louarn, J. M.,
and Georgopoulous, C.
(1986)
Mol. Gen. Genet.
202,
435-445[CrossRef][Medline]
[Order article via Infotrieve]
|
| 36.
|
Georgopoulos, C. P.,
Hendrix, R. W.,
Casjens, S.,
and Kaiser, A. D.
(1973)
J. Mol. Biol.
76,
45-60[CrossRef][Medline]
[Order article via Infotrieve]
|
| 37.
|
Zeilstra-Ryalls, J.,
Fayet, O.,
Baird, L.,
and Georgopoulos, C.
(1993)
J. Bacteriol.
175,
1134-1143[Abstract/Free Full Text]
|
| 38.
|
Neal, B. L.,
Brown, P. K.,
and Reeves, P. R.
(1993)
J. Bacteriol.
175,
7115-7118[Abstract/Free Full Text]
|
| 39.
|
Fane, B.,
and King, J.
(1991)
Genetics
127,
263-277[Abstract]
|
| 40.
|
Kwok, S.,
Kellogg, D. E.,
McKinney, N.,
Spasic, D.,
Gorda, L.,
Levenson, C.,
and Sninsky, J. J.
(1990)
Nucleic Acids Res.
18,
999-1005[Abstract/Free Full Text]
|
| 41.
|
Sommer, S. S.,
Groszbach, A. R.,
and Bottema, C. D. K.
(1992)
BioTechiques
12,
82-87[Medline]
[Order article via Infotrieve]
|
| 42.
|
Bottema, C. D. K.,
Sarkar, G.,
Cassady, J. D.,
Ii, S.,
Dutton, C. M.,
and Sommer, S. S.
(1993)
Methods Enzymol.
218,
388-402[Medline]
[Order article via Infotrieve]
|
| 43.
|
Eppler, K.,
Wykoff, E.,
Goates, J.,
Parr, R.,
and Casjens, S.
(1991)
Virology
183,
519-538[CrossRef][Medline]
[Order article via Infotrieve]
|
| 44.
|
Fong, D. G.,
Doyle, S. M.,
and Teschke, C. M.
(1997)
Biochemistry
36,
3971-3980[CrossRef][Medline]
[Order article via Infotrieve]
|
| 45.
|
King, J.,
Fane, B.,
Haase-Pettingell, C.,
Mitraki, A.,
Villafane, R.,
and Yu, M.-h.
(1989)
in
Protein Folding: Deciphering the Second Half of the Genetic Code
(Gierasch, L. M.
, and King, J., eds)
, pp. 225-239, American Association for the Advancement of Science, Washington, D. C.
|
| 46.
|
Haase-Pettingell, C.,
and King, J.
(1988)
J. Biol. Chem.
263,
4977-4983[Abstract/Free Full Text]
|
| 47.
|
Mitraki, A.,
Haase-Pettingell, C.,
and King, J.
(1991)
in
Protein Refolding
(Georgiou, G.
, and de Bernardez, E., eds)
, pp. 35-49, American Chemical Society, Washington, D. C.
|
| 48.
|
Mitraki, A.,
Fane, B.,
Haase-Pettingell, C.,
Sturtevant, J.,
and King, J.
(1991)
Science
253,
54-58[Abstract/Free Full Text]
|
| 49.
|
Mitraki, A.,
Danner, M.,
King, J.,
and Seckler, R.
(1993)
J. Biol. Chem.
268,
20071-20075[Abstract/Free Full Text]
|
| 50.
|
Wetzel, R.
(1994)
TibTech
12,
193-198
|
| 51.
|
King, R. D.,
and Sternberg, M. J. E.
(1996)
Protein Sci.
5,
2298-2310[Abstract]
|
| 52.
|
Gough, M.,
and Levine, M.
(1968)
Genetics
58,
161-169[Free Full Text]
|
| 53.
|
Botstein, D.,
Chan, R. K.,
and Waddell, C. H.
(1972)
Virology
49,
268-282[CrossRef][Medline]
[Order article via Infotrieve]
|
| 54.
|
Teschke, C. M.,
and King, J.
(1993)
Biochemistry
32,
10839-10847[CrossRef][Medline]
[Order article via Infotrieve]
|
| 55.
|
Teschke, C. M.,
and King, J.
(1995)
Biochemistry
34,
6815-6826[CrossRef][Medline]
[Order article via Infotrieve]
|
| 56.
|
Teschke, C. M.,
and Fong, D. G.
(1996)
Biochemistry
35,
14831-14840[CrossRef][Medline]
[Order article via Infotrieve]
|
| 57.
|
Li, Y.,
Thomas, G. J. J.,
Fuller, M.,
and King, J.
(1981)
Bacteriophage Assembly: Investigations of Bacteriophage P 22 by Laser Raman Spectroscopy
, Alan R. Liss, Inc., New York
|
| 58.
|
King, J.,
Haase-Pettingell, C.,
Skaja Robinson, A. S.,
Speed, M.,
and Mitraki, A.
(1996)
FASEB J.
10,
57-66[Abstract]
|
| 59.
|
Chothia, C.
(1984)
Annu. Rev. Biochem.
53,
537-572[CrossRef][Medline]
[Order article via Infotrieve]
|
| 60.
|
Creighton, T. E.
(1993)
Proteins
, pp. 171-199, W. H. Freeman & Co., New York
|
| 61.
|
Bowie, J. U.,
Reidhaar-Olson, J. F.,
Lim, W., A.,
and Sauer, R. T.
(1990)
Science
247,
1306-1310[Abstract/Free Full Text]
|
| 62.
|
Zhang, J.-X.,
and Goldenberg, D. P.
(1997)
Protein Sci.
6,
1549-1562[Abstract]
|
| 63.
|
Zhang, J.-X.,
and Goldenberg, D. P.
(1997)
Protein Sci.
6,
1563-1576[Abstract]
|
| 64.
|
Van der Schueren, J.,
Robben, J.,
and Volckaert, G.
(1998)
Protein Eng.
11,
1211-1217[Abstract/Free Full Text]
|
| 65.
|
Tuma, R.,
Prevelige, P., E., Jr.,
and Thomas, G., J., Jr.
(1998)
Proc. Natl. Acad. Sci. U. S. A.
95,
9885-9890[Abstract/Free Full Text]
|
| 66.
|
Fane, B.,
and King, J.
(1987)
Genetics
117,
157-171[Abstract/Free Full Text]
|
| 67.
|
Steinbacher, S.,
Seckler, R.,
Miller, S.,
Steipe, B.,
Huber, R.,
and Reinemer, P.
(1994)
Science
265,
383-386[Abstract/Free Full Text]
|
| 68.
|
Steinbacher, S.,
Miller, S.,
Baxa, U.,
Budisa, N.,
Weintraub, A.,
Seckler, R.,
and Huber, R.
(1997)
J. Mol. Biol.
267,
865-880[CrossRef][Medline]
[Order article via Infotrieve]
|
| 69.
|
Schuler, B.,
and Seckler, R.
(1998)
J. Mol. Biol.
281,
227-234[CrossRef][Medline]
[Order article via Infotrieve]
|
Copyright © 1999 by The American Society for Biochemistry and Molecular Biology, Inc.

CiteULike
Complore
Connotea
Del.icio.us
Digg
Reddit
Technorati What's this?
This article has been cited by other articles:

|
 |

|
 |
 
S. M. Doyle, E. Anderson, K. N. Parent, and C. M. Teschke
A Concerted Mechanism for the Suppression of a Folding Defect through Interactions with Chaperones
J. Biol. Chem.,
|